Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors
Abstract The proteasome of the malaria parasite Plasmodium falciparum (Pf20S) is an advantageous drug target because its inhibition kills P. falciparum in multiple stages of its life cycle and synergizes with artemisinins. We recently developed a macrocyclic peptide, TDI-8304, that is highly selecti...
Main Authors: | Hao-Chi Hsu, Daqiang Li, Wenhu Zhan, Jianxiang Ye, Yi Jing Liu, Annie Leung, Junling Qin, Benigno Crespo, Francisco-Javier Gamo, Hao Zhang, Liwang Cui, Alison Roth, Laura A. Kirkman, Huilin Li, Gang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-44077-2 |
Similar Items
-
Protocol for analysis of intracellular conversion of artezomib molecules into new proteasome inhibitors in Plasmodium falciparum parasites
by: Wenhu Zhan, et al.
Published: (2024-03-01) -
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
by: Faiza Amber Siddiqui, et al.
Published: (2021-08-01) -
Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
by: Adriana F. Gonçalves, et al.
Published: (2024-02-01) -
Comprehensive study of proteasome inhibitors against <it>Plasmodium falciparum </it>laboratory strains and field isolates from Gabon
by: Kremsner Peter G, et al.
Published: (2008-09-01) -
A Leak-Free Inducible CRISPRi/a System for Gene Functional Studies in Plasmodium falciparum
by: Xiaoying Liang, et al.
Published: (2022-06-01)